Results
|
601.
|
|
|
602.
|
|
|
603.
|
|
|
604.
|
|
|
605.
|
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. [electronic resource] by
- Trigg, Ricky M
- Lee, Liam C
- Prokoph, Nina
- Jahangiri, Leila
- Reynolds, C Patrick
- Amos Burke, G A
- Probst, Nicola A
- Han, Miaojun
- Matthews, Jamie D
- Lim, Hong Kai
- Manners, Eleanor
- Martinez, Sonia
- Pastor, Joaquin
- Blanco-Aparicio, Carmen
- Merkel, Olaf
- de Los Fayos Alonso, Ines Garces
- Kodajova, Petra
- Tangermann, Simone
- Högler, Sandra
- Luo, Ji
- Kenner, Lukas
- Turner, Suzanne D
Producer: 20200302
In:
Nature communications vol. 10
Availability: No items available.
|
|
606.
|
|
|
607.
|
|
|
608.
|
PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value. [electronic resource] by
- Xu, Jianwei
- Xiong, Guangbing
- Cao, Zhe
- Huang, Hua
- Wang, Tianxiao
- You, Lei
- Zhou, Li
- Zheng, Lianfang
- Hu, Ya
- Zhang, Taiping
- Zhao, Yupei
Producer: 20171213
In:
Journal of experimental & clinical cancer research : CR vol. 35
Availability: No items available.
|
|
609.
|
|
|
610.
|
MiR-328 targeting PIM-1 inhibits proliferation and migration of pulmonary arterial smooth muscle cells in PDGFBB signaling pathway. [electronic resource] by
- Qian, Zhengjiang
- Zhang, Limin
- Chen, Jidong
- Li, Yanjiao
- Kang, Kang
- Qu, Junle
- Wang, Zhiwei
- Zhai, Yujia
- Li, Li
- Gou, Deming
Producer: 20180118
In:
Oncotarget vol. 7
Availability: No items available.
|
|
611.
|
|
|
612.
|
|
|
613.
|
|
|
614.
|
|
|
615.
|
|
|
616.
|
|
|
617.
|
|
|
618.
|
|
|
619.
|
|
|
620.
|
The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN. [electronic resource] by
- Mazzacurati, Lucia
- Collins, Robert J
- Pandey, Garima
- Lambert-Showers, Que T
- Amin, Narmin E
- Zhang, Ling
- Stubbs, Matthew C
- Epling-Burnette, Pearlie K
- Koblish, Holly K
- Reuther, Gary W
Producer: 20200908
In:
Blood advances vol. 3
Availability: No items available.
|